CompletedNCT03334721
Gabapentin for Cannabis Use in People With Bipolarity
About this title
Read the official source — NCT03334721Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- CharlestonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: October 1, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 23
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03334721
- Official title
Show the full official title
Gabapentin for Bipolar & Cannabis Use Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Charleston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical University of South Carolina, a university.
Did this study involve medication?
Yes. The study involved medication, including Gabapentin and Placebo Oral Capsule.
Who was this study for?
Listed age limits: 18 years to 65 years.
